Exploring New Jersey's Vibrant Medtech Landscape Through Edge Medical Ventures Event

A Flourishing Medtech Ecosystem: Edge Medical Ventures in New Jersey

New Jersey is rapidly establishing itself as a hub for medical technology innovation, as evidenced by a recent event hosted by Edge Medical Ventures at the Liberty Science Center. This gathering brought together a diverse group of stakeholders, including investors, entrepreneurs, healthcare leaders, and public-sector representatives, all keen on exploring the state's expanding medtech landscape.

The Medtech Innovation Showcase, held on January 20, 2026, highlighted the significant role of Edge Medical Ventures in addressing unmet clinical needs through its unique dual venture creation and investment model. Edge Medical Ventures operates as both a venture fund and a studio, focusing on nurturing startups in the medical device sector.

Edge has developed a transatlantic model that allows medtech startups to conduct early-stage research and development in Israel before progressing to clinical and commercial activities in the U.S. This model not only leverages highly differentiated innovation but also optimizes capital efficiency, making New Jersey an attractive destination for foreign companies looking to scale their U.S. operations.

Shai Policker, the Managing Partner of Edge Medical Ventures, kicked off the event by outlining the dual fund and studio model that anchors Edge's operations in New Jersey. He emphasized how the collaboration between Edge and the New Jersey Economic Development Authority (NJEDA) through the NJ Innovation Evergreen Fund (NJIEF) has been pivotal in establishing local medtech companies. "By embedding operational, clinical, regulatory, and U.S. go-to-market expertise into the early plans of startups, we enable them to progress efficiently toward clinical validation and commercialization," Policker stated.

The keynote speakers included Paul Hoffmann, President and CEO of Liberty Science Center, who spoke of the center's role as a platform for innovation. Alexander Richter, Executive Director of the SciTech Innovation Hub, highlighted the efforts being made to strengthen New Jersey's innovation ecosystem and attract high-growth tech companies.

A prominent theme throughout the event was the significance of public-private partnerships in promoting healthcare innovation. Representatives from NJEDA discussed how state programs actively work to draw investment, anchor companies, and retain essential talent within New Jersey's life sciences sector. John Coelho emphasized the transition from a reliance on large companies to a more diversified ecosystem, spotlighting biotechnology's relationship with medtech.

During the event, Edge's status as a Qualified Venture Fund for NJEDA's Innovation Evergreen Fund was underscored; this allows for co-investment alongside state funds into local medtech startups, enriching the investment ecosystem within the state. Additionally, the recent announcement of a $1 million investment from NJIEF into Edge portfolio company Synchrony Medical exemplifies the success of this model.

A panel discussion featuring representatives from three startups launched from Edge’s venture studio—Exero Medical, Urologic Health, and Synchrony Medical—provided insights into the advantages of operating within Edge's framework. Panelists shared updates on recent achievements, including clinical study completions, pilot program developments, and regulatory advancements that are crucial for market entry.

The Medtech Innovation Showcase effectively illustrated how Edge's model supports the establishment of successful medical technology companies in New Jersey. This event is not just a one-off; it reflects a broader trend where the state is increasingly recognized as a key player for international startups benefiting from a rich network of local health systems, research institutions, and funding support.

In conclusion, Edge Medical Ventures is at the forefront of cultivating a robust medtech ecosystem in New Jersey. With its commitment to fostering innovation and collaboration between startups and established healthcare systems, Edge is poised to significantly influence the advancement of medical technologies. As New Jersey continues to be a focal point for healthcare innovation, the partnerships and investments forged today will pave the way for future breakthroughs in the medical field.

For more detailed information about Edge Medical Ventures and their projects, please visit Edge Medical Ventures.